Single-center pilot study reports neurodevelopmental outcomes in infants receiving ductus arteriosus stenting versus surgical shunt, highlighting differences in early cognitive development.
Patent ductus arteriosus stenting (PDAS) is a nonsurgical alternative to Blalock-Taussig-Thomas shunt (BTTS) for infants with ductal-dependent congenital heart disease. In this single-center study, we aimed to compare neurodevelopmental outcomes in children who underwent BTTS as initial palliation versus PDAS.
No takes yet. Share an insight, caveat, or question.
El‐Said et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: